MarketCap
Facebook
X
TelegramAphria Inc. P/CF 2011-2026 | APHA
P/CF Jährlich Aphria Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| -4.16 | -6.51 | -6.74 | -6.86 | -12.7 | -4.73 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -4.16 | -12.7 | -6.95 |
P/CF anderer Aktien in der Pharmaeinzelhändler
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M |  Germany |
 |
Acer Therapeutics
ACER
|
-0.401 | - | 2.71 % | $ 14 M |  USA |
 |
Acorda Therapeutics
ACOR
|
-1.2 | - | -24.86 % | $ 820 K | USA |
 |
AgeX Therapeutics
AGE
|
-0.0018 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
-0.64 | - | - | $ 26.5 M | USA |
 |
AbCellera Biologics
ABCL
|
-7.33 | $ 3.55 | -2.18 % | $ 1.06 B |  Canada |
 |
I-Mab
IMAB
|
-0.266 | - | - | $ 866 M |  China |
 |
ADMA Biologics
ADMA
|
75 | $ 15.66 | -5.32 % | $ 3.73 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M |  France |
 |
Aptorum Group Limited
APM
|
-3.44 | $ 0.82 | -0.73 % | $ 4.47 M | China |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B | USA |
 |
Akouos
AKUS
|
-2.7 | - | 0.23 % | $ 488 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-6.14 | - | - | $ 2.17 B | USA |
 |
AlloVir
ALVR
|
-0.723 | - | 4.14 % | $ 49.1 M | USA |
 |
Apellis Pharmaceuticals
APLS
|
61.2 | $ 20.16 | 1.51 % | $ 2.54 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-0.0776 | - | -11.43 % | $ 502 K | USA |
 |
ANI Pharmaceuticals
ANIP
|
18.7 | $ 75.5 | -1.35 % | $ 1.46 B | USA |
 |
Applied Therapeutics
APLT
|
-9.8 | - | - | $ 8.42 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
-2.05 | $ 1.48 | -9.2 % | $ 378 M | Britain |
 |
Aravive
ARAV
|
-0.928 | - | -13.39 % | $ 1.45 M | USA |
 |
Adverum Biotechnologies
ADVM
|
-0.826 | - | - | $ 86.2 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - |  Russia |
 |
Athersys
ATHX
|
-5.78 | - | 3.77 % | $ 22.4 M | USA |
 |
ARCA biopharma
ABIO
|
-8.36 | - | 1052.0 % | $ 415 M | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
26.4 | $ 34.35 | -3.75 % | $ 3.57 B | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
-1.25 | $ 7.8 | -7.36 % | $ 33.8 M | USA |
 |
CorMedix
CRMD
|
-4.53 | $ 6.32 | -11.24 % | $ 322 M | USA |
 |
AVEO Pharmaceuticals
AVEO
|
-1.71 | - | - | $ 521 M | USA |
 |
Champions Oncology
CSBR
|
14.3 | $ 5.79 | -3.58 % | $ 79.1 M | USA |
 |
Axsome Therapeutics
AXSM
|
-92.9 | $ 160.44 | -2.22 % | $ 7.98 B | USA |
 |
BridgeBio Pharma
BBIO
|
-29.4 | $ 65.38 | -1.74 % | $ 12.5 B | USA |
 |
Denali Therapeutics
DNLI
|
-8.74 | $ 19.69 | -3.34 % | $ 3.24 B | USA |
 |
Brainstorm Cell Therapeutics
BCLI
|
-0.696 | - | -2.5 % | $ 5.88 M | USA |
 |
BioDelivery Sciences International
BDSI
|
7.5 | - | -4.8 % | $ 255 M | USA |
 |
Acasti Pharma
ACST
|
-2.73 | - | 4.01 % | $ 150 M | Canada |
 |
BeiGene, Ltd.
BGNE
|
-1.8 K | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Edesa Biotech
EDSA
|
-1.24 | $ 3.8 | -10.9 % | $ 12.2 M | USA |
 |
Equillium
EQ
|
-3.89 | $ 1.79 | 2.0 % | $ 62.2 M | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
-0.323 | - | -9.72 % | $ 5.89 M | USA |
 |
Berkeley Lights
BLI
|
-2.46 | - | -7.31 % | $ 87 M | USA |
 |
CureVac N.V.
CVAC
|
-4.82 | - | - | $ 867 M | Germany |
 |
Aeterna Zentaris
AEZS
|
-4.82 | - | 5.93 % | $ 314 M | Canada |
 |
Bellerophon Therapeutics
BLPH
|
-4.42 | - | -74.18 % | $ 955 K | USA |
 |
BioLineRx Ltd.
BLRX
|
-57.4 | $ 2.75 | -2.14 % | $ 908 M |  Israel |
 |
BioMarin Pharmaceutical
BMRN
|
14.1 | $ 60.47 | 0.07 % | $ 11.6 B | USA |
 |
Eton Pharmaceuticals
ETON
|
16.8 | $ 17.04 | -2.77 % | $ 437 M | USA |